Literature DB >> 20138448

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.

F Medkour, S Babai, E Chanteloup, V Buffard, J-C Delchier, H Le-Louet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20138448     DOI： 10.1016/j.gcb.2009.10.021

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN： 0399-8320


× No keyword cloud information.
  5 in total

Review 1.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

2.  Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.

Authors:  Adam V Weizman; Brian Huang; Stephan Targan; Marla Dubinsky; Phillip Fleshner; Manreet Kaur; Andrew Ippoliti; Deepa Panikkath; Eric Vasiliauskas; David Shih; Dermot P B McGovern; Gil Y Melmed
Journal:  J Cutan Med Surg       Date:  2014-10       Impact factor: 2.092

3.  Alopecia secondary to anti-tumor necrosis factor-alpha therapy.

Authors:  Lara Beatriz Prata Ribeiro; Juliana Carlos Gonçalves Rego; Bruna Duque Estrada; Paula Raso Bastos; Juan Manuel Piñeiro Maceira; Celso Tavares Sodré
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

4.  Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn's disease.

Authors:  Hitoshi Amano; Reikei Matsuda; Tomohiko Shibata; Daisuke Takahashi; Shinichiro Suzuki
Journal:  Biologics       Date:  2017-05-22

5.  Tumor Necrosis Factor-Alpha Inhibitor-Associated Psoriatic Alopecia in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature.

Authors:  Kyung Muk Jeong; Ji Yun Seo; Anna Kim; Yoo Sang Baek; Hae Jun Song; Jiehyun Jeon
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.